Patients, analysts may be overreacting to recent drug problems

12/28/2004 | NYTimes.com · FoxNews.com

Physicians are concerned patients will abandon necessary drugs as an overreaction to recent announcements of problems found with Cox-2 inhibitors and related drugs, even though studies show most people tend to accept some level of danger to get relief. Stock analysts say investors also may be overreacting in selling off their pharmaceutical stocks, citing "the vast majority of drugs are safe" and "drug companies aren't going out of business."

View Full Article in:

NYTimes.com · FoxNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA